Neuroblastoma Research and Treatments
Open access
Peer reviewed
Scollr summary
What this paper is about
A review of the clinical use of the humanized mAb Hu3F8, the efficacy of which has been demonstrated in clinical trials and which has been demonstrated in clinical trials.
Full abstract
Read the full abstract
Despite the use of multimodal therapy in patients with high-risk neuroblastoma (NB), the prognosis in high-risk patients remains unfavorable. Immunotherapy with monoclonal antibodies (mAb) in the post-consolidation period of treatment of high-risk NB has marked significant progress in improving the prognosis for patients who have achieved a good response to first-line therapy. Currently, the US Food and Drug Administration has approved three mAb drugs for the treatment of patients with high-risk NB: dinutuximab (Ch14.18), dinutuximab beta (Ch14.18/CHO), and naxitamab (Hu3F8). This publication is devoted to a review of the clinical use of the humanized mAb Hu3F8, the efficacy of which has been demonstrated in clinical trials.
Direct answer
What can I do from this paper page?
Use this page to scan "Treatment of patients with high-risk neuroblastoma using a humanized monoclonal antibody" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Neuroblastoma Research and Treatments, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Sagoyan2026Treatment,
title = {Treatment of patients with high-risk neuroblastoma using a humanized monoclonal antibody},
author = {G. B. Sagoyan and А. M. Suleymanova and M. V. Rubanskaya and К. И. Киргизов and С. Р. Варфоломеева},
journal = {Russian Journal of Pediatric Hematology and Oncology},
year = {2026},
doi = {10.21682/2311-1267-2026-13-2-98-107},
url = {https://doi.org/10.21682/2311-1267-2026-13-2-98-107}
}FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Neuroblastoma Research and Treatments papers?
Follow Neuroblastoma Research and Treatments in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Treatment of patients with high-risk neuroblastoma using a humanized monoclonal antibody. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app